BioRestorative Therapies Inc.
BRTX | NASDAQ
$2.60
-$0.11 (-4.06%)
Sep 22, 2026, 10:32 AM ET · Market open
TTM Period Ending | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 357.87K | 359.7K | 383.4K | 605.2K | 391K | 401K | 377K | 174.1K | 149.5K | 145.8K | 130.2K | 128.5K | 135.1K | 119.8K | 121.1K | 100.1K | 44K | 46K | 58K | 65K | 69K |
Cost of Revenue | 28.32K | 23.84K | 25.55K | 33.22K | 30.98K | 28.07K | 67.45K | 49.2K | 42.71K | 42.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 329.55K | 335.86K | 357.85K | 571.98K | 360.02K | 372.93K | 309.55K | 124.9K | 106.79K | 103.09K | 130.2K | 128.5K | 135.1K | 119.8K | 121.1K | 100.1K | 44K | 46K | 58K | 65K | 69K |
Operating Income | -14.23M | -15.65M | -14.51M | -13.09M | -12.25M | -11.56M | -12.09M | -12.9M | -13.55M | -15.22M | -16.68M | -18.19M | -19.7M | -18.97M | -18.3M | -17.38M | -16.31M | -26.31M | -23.15M | -20.07M | -16.98M |
Interest Income | 171.72K | 266.21K | 350.61K | 451.42K | 553.45K | 616.08K | 873.31K | 776.43K | 696.67K | 552.29K | 292.19K | 230.52K | 134.33K | 116.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -11.06M | -14.24M | -12.67M | -10.72M | -12.1M | -8.98M | -6.17M | -310.99K | -1.99M | -6.94M | -12.46M | -21.89M | -20.85M | -18.49M | -34.55M | -34.08M | -33.47M | -44.3M | -29.66M | -26.31M | -19.38M |
Net Income | -11.06M | -14.24M | -12.67M | -10.72M | -12.1M | -8.98M | -6.17M | -310.99K | -1.99M | -6.94M | -12.46M | -21.89M | -20.85M | -18.49M | -34.55M | -34.08M | -33.47M | -44.3M | -29.66M | -26.31M | -19.38M |
Selling & General & Admin | 5.18M | 6.82M | 6.68M | 6.74M | 6.63M | 6.6M | 8.04M | 9.19M | 10.21M | 11.7M | 13.19M | 14.52M | 15.86M | 15.58M | 15.42M | 15.23M | 15.01M | 25.59M | 22.43M | 19.34M | 16.15M |
Research & Development | 9.37M | 9.16M | 8.19M | 6.92M | 5.98M | 5.33M | 4.35M | 3.84M | 3.45M | 3.63M | 3.62M | 3.8M | 3.97M | 3.51M | 3.01M | 2.25M | 1.34M | 729.06K | 741.47K | 755.1K | 855.76K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39.59K | 39.59K | 39.59K | 39.59K |
Operating Expenses | 14.55M | 15.98M | 14.87M | 13.66M | 12.61M | 11.93M | 12.4M | 13.03M | 13.66M | 15.32M | 16.81M | 18.32M | 19.83M | 19.09M | 18.42M | 17.48M | 16.35M | 26.35M | 23.21M | 20.14M | 17.05M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 176.07K | 176.07K | 176.07K | 176.07K | n/a | 28.84K | 75.45K | 104.47K | 318.28K | 784.98K | 1.25M | 1.82M | 1.83M | 1.38M | 893.14K |
Selling & Marketing Expenses | n/a | n/a | 173.06K | 173.06K | 173.06K | 173.06K | -706 | -706 | -706 | -706 | n/a | n/a | 245 | 714 | 3.88K | 3.88K | 9.86K | 11.99K | 47.26K | 47.41K | 47.31K |
Cost & Expenses | 14.58M | 16.01M | 14.9M | 13.7M | 12.64M | 11.96M | 12.46M | 13.08M | 13.7M | 15.37M | 16.81M | 18.32M | 19.83M | 19.09M | 18.42M | 17.48M | 16.35M | 26.35M | 23.21M | 20.14M | 17.05M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 886.39K | 443.81K | 455.81K | 437.02K | 417.86K | 346K | 406.08K | 406.08K | 333.57K | 235.35K | 228.54K | 194.32K | 185.87K | 183.36K | 182.11K | 181.92K | 176.16K | 176.02K | 41.93K | 39.79K | 36.5K |
Shares Outstanding (Diluted) | 886.39K | 443.81K | 455.81K | 437.02K | 417.86K | 346K | 406.08K | 406.08K | 333.57K | 235.35K | 616.24K | 194.32K | 185.87K | 183.36K | 182.11K | 181.92K | 176.16K | 176.02K | 41.93K | 39.79K | 36.5K |
EPS (Basic) | -22.20 | -32.60 | -30.20 | -26.20 | -30.20 | -24 | -14.20 | 9.20 | -10.20 | -42.20 | -71 | -117.40 | -113.60 | -102.40 | -194.60 | -269 | -345.80 | -747.20 | -884 | -825.60 | -579.20 |
EPS (Diluted) | -22.20 | -32.60 | -30.20 | -26.20 | -30.20 | -24 | -14.20 | -3.80 | -23.20 | -55.20 | -84 | -117.40 | -113.60 | -102.40 | -194.60 | -269 | -345.80 | -747.20 | -884 | -825.60 | -579.20 |
EBITDA | -10.85M | -14.03M | -12.46M | -10.52M | -11.9M | -8.79M | -5.81M | -7.75M | -9.44M | -14.39M | -20.02M | -21.61M | -20.54M | -18.14M | -34.03M | -33.14M | -32.07M | -42.37M | -23.06M | -20.16M | -13.7M |
EBIT | -11.06M | -14.24M | -12.67M | -10.72M | -12.1M | -8.98M | -5.99M | -7.92M | -9.61M | -14.55M | -20.25M | -21.86M | -20.78M | -18.39M | -34.23M | -33.29M | -32.22M | -42.49M | -23.15M | -20.26M | -13.8M |
Depreciation & Amortization | 210.6K | 209.99K | 207.52K | 203.17K | 198.12K | 189.06K | 181.4K | 175.28K | 169.1K | 165.74K | 227.9K | 246K | 235.98K | 251.66K | 197.33K | 158.67K | 148.99K | 118.17K | 93.08K | 96.97K | 101.82K |
Add to Watchlist
Select watchlists to add or remove BRTX